
 
              • 311529
 
            | Product name | B-mSiglec15 MC38 | 
|---|---|
| Catalog number | 311529 | 
| Strain background | C57BL/6 | 
| NCBI gene ID | 620235 (Mouse) | 
| Aliases | Cd33l; Cd33l3; EG620235; SIGLEC-I; Cd33l; Cd33l3; EG620235; SIGLEC-I | 
| Tissue | Colon | 
| Disease | Colon carcinoma | 
| Species | Mouse | 
| Application | B-mSiglec15 MC38 cells have the capability to establish tumors in vivo | 

The mouse Siglec15 gene was insert into mouse ROSA26 site. Mouse Siglec15 is highly expressed on the surface of B-mSiglec15 MC38 cells.

Gene targeting strategy for B-mSiglec15 MC38.The mouse Siglec15 CDS was insert into mouse ROSA26 site in B-mSiglec15 MC38.

 
              The Siglec15 expression analysis in B-mSiglec15 MC38 cells by flow cytometry. Single cells were collected from wild-type MC38 and B-mSiglec15 MC38 cells, and analyzed by flow cytometry with anti-human and mouse SIGLEC15 antibody(SIGLEC15-5G12, in house). Mouse Siglec15 was exclusively detectable in B-mSiglec15 MC38 cells but not wild-type MC38 cells. The 2-C12 clone of B-mSiglec15 MC38 cells was used for in vivo experiments.

 
              B-mSiglec15 MC38 cells were transplanted into C57BL/6N mice (n=5), and on 28 days post inoculation, certain volumes of tumors as was taken to detect the expression level of the cells. Cells were analyzed by flow cytometry with anti-human and mouse SIGLEC15 antibody (SIGLEC15-5G12, in house). As shown, mouse Siglec15 was highly expressed on the surface of B-mSiglec15 MC38 tumor cells. B-mSiglec15 MC38 can be used for in vivo efficacy validation.

 
              
 
              B-mSiglec15 MC38 tumor cells growth of individual mice. B-mSiglec15 MC38 cells (5x105) and wild-type MC38 cells (5x105 ) were subcutaneously implanted into the C57BL/6N mice (female, 5-8 week-old, n=5). As shown in panel, B-mSiglec15 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.